Practice imperfect—repeated cognitive testing can obscure early signs of dementia

July 12, 2018, University of California - San Diego
Credit: CC0 Public Domain

Alzheimer's disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

But in a paper published online in the journal Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, a team of researchers led by scientists at the University of California San Diego School of Medicine found that repeated testing of middle-age men produced a "practice effect" which obscured true cognitive decline and delayed detection of MCI.

"When persons take the same or similar tests repeatedly over time, they simply get better at taking the tests," said first author Jeremy A. Elman, Ph.D., a postdoctoral fellow in the lab of senior author William S. Kremen, Ph.D., professor of psychiatry and co-director with Carol E. Franz, Ph.D., of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine. "The consequence is that their results may not accurately reflect the reality of their condition."

Researchers re-tested 995 middle- to late-middle-aged men in a six-year follow-up of the Vietnam Era Twin Study of Aging (a longitudinal study of male-male twins who had all served in the military sometime between 1965 and 1975, though almost 80 percent reported no combat exposure). A second group of 170 age-matched males were tested for the first time. Group differences were used to calculate practice effects.

The scientists found that there were significant practice effects in most cognitive domains, and diagnoses of MCI doubled from 4.5 to 9 percent after correcting for practice effects. "In other words," said Kremen, "some men would have declined to levels indicating impairment on follow-up testing had they not been exposed to the tests before."

The authors said the disparity has significant clinical consequences. Consider, for example, two people with similar characteristics who have identical cognitive scores just above the threshold for an MCI diagnosis. The only difference: One individual is being tested for the first time while the other has taken such tests before.

"We can infer that the second individual may actually have more impairment, but the effects of practice are artificially increasing their scores," wrote the authors. "This scenario would suggest that the individual may have dipped below the norm-based threshold and would have been diagnosed as having MCI had the test been taken for the first time."

The clinical significance, they said, is that treatment for AD is shifting increasingly toward prevention strategies that rely on early identification. The researchers say their findings strongly suggest the importance of correcting for effects in longitudinal studies of older adults, such as using similar replacement persons taking the test for the first time.

Explore further: Polygenic risk score may identify alzheimer's risk in younger populations

More information: Jeremy A. Elman et al, Underdiagnosis of mild cognitive impairment: A consequence of ignoring practice effects, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (2018). DOI: 10.1016/j.dadm.2018.04.003

Related Stories

Polygenic risk score may identify alzheimer's risk in younger populations

March 5, 2018
For the first time, an international team of scientists, led by researchers at University of California San Diego School of Medicine, have determined that an Alzheimer's disease (AD) polygenic risk score can be used to correctly ...

Diagnosis of Alzheimer's becoming more common, but less severe

June 26, 2018
Alzheimer's disease is the most common form of dementia, affecting nearly six million Americans. Aside from the incredible toll it takes on patients and their families, the estimated total cost of care is over $400 billion. ...

Late, but not too late—screening for olfactory dysfunction

April 20, 2018
In a large population-based study of randomly selected participants in Germany, researchers found that participants aged 65-74 years with olfactory dysfunction showed impaired cognitive performance. Interestingly, this strong ...

The role of verb fluency in the detection of early cognitive impairment in Alzheimer's disease

March 16, 2018
The ability to generate spoken verbs in infinitive in a given time begins to worsen in the early stages of Alzheimer's disease (AD). Thus, the verb fluency test has been found to be a suitable neuropsychological tool for ...

What if you could know that your mild cognitive impairment wouldn't progress

April 24, 2018
Researchers from the Lisbon School of Medicine, University of Lisbon found that, in some mild cognitive impairment patients, real neuropsychological stability over a decade is possible and that long-term stability could be ...

Alzheimer's drug prescribed 'off-label' for mild cognitive impairment could pose risk for some

February 24, 2017
Donepezil, a medication that is approved to treat people with Alzheimer's disease, should not be prescribed for people with mild cognitive impairment without a genetic test. UCLA School of Nursing researchers discovered that ...

Recommended for you

Meditation and music may alter blood markers of cellular aging and Alzheimer's disease

November 13, 2018
A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer's ...

Alzheimer's and cardiovascular disease share common genetics in some patients

November 9, 2018
Genetics may predispose some people to both Alzheimer's disease and high levels of blood lipids such as cholesterol, a common feature of cardiovascular disease, according to a new study by an international team of researchers ...

Artificial intelligence predicts Alzheimer's years before diagnosis

November 6, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer's disease, according to a study published in the journal Radiology.

Diabetes medications may reduce Alzheimer's disease severity

November 1, 2018
People with Alzheimer's disease who were treated with diabetes drugs showed considerably fewer markers of the disease—including abnormal microvasculature and disregulated gene expressions—in their brains compared to Alzheimer's ...

Massive study confirms that loneliness increases risk of dementia

October 29, 2018
A new Florida State University College of Medicine study involving data from 12,000 participants collected over 10 years confirms the heavy toll that loneliness can take on your health: It increases your risk of dementia ...

Bioactive compound from the Rhodiola plant improves memory

October 25, 2018
In an ageing society, more people are suffering from memory disorders. The progressive loss of memory severely impairs the quality of life of those affected. So far, no drugs are known to prevent age-related cognitive decline.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.